Selected References:

• Anderson PO. 2021. Monoclonal antibodies during breastfeeding. Breastfeeding Medicine. 16(8): 591-93. 
• Noseda R, et al. 2024. Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase®. Clin Pharmacol Ther. 116(2)346-350. 
• Praluent® Prescribing Information. Available online at: https://www.regeneron.com/downloads/praluent_pi.pdf. Accessed April 1, 2026 
• Vuignier Y, et al. 2021. Exposure to alirocumab during the first trimester of pregnancy: A case report. Birth Defects Research. 113(15): 1156–60.  

Selected References:

• ACOG. 1993. Hepatitis in pregnancy. ACOG Technical Bulletin Number 174–November 1992. Int J Gynaecol Obstet. 42(2):189-98. 
• Celzo F et al. 2020. Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy. Vaccine; 38(40):6215-6223. 
• Chilaka VN, Konje JC. 2020. Viral Hepatitis in Pregnancy. Eur J Obstet Gynecol Reprod Biol; 256:287-296. 
• Cho GJ, et al. 2013. Hepatitis A virus infection during pregnancy in Korea: Hepatitis A infection on pregnant women. Obstet Gynecol Sci; 56(6):368-374.  
• D’Acremont V, et al. 2008. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med; 15(2):77-81.  
• Daudi N, et al. 2012. Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection. Breastfeed Med; 7:313-315. 
• Dionne-Odom J, et al. 2022. Treatment and prevention of viral hepatitis in pregnancy. Am J Obstet Gynecol; 226(3):335-346.  
• Duff P. 1998. Hepatitis in Pregnancy. Semin Perinatol; 22(4):277-283.  
• Elinav E, et al. 2006. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology; 130(4):1129-1134.  
• Groom HC, et al. 2019. Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study. Vaccine; 37(44):6648-6655. 
• Lemon SM. 1997. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem; 43(8 Pt 2):1494-1499.  
• Motte A, et al. 2009. Acute hepatitis A in pregnant women at delivery. Int J infect Dis; 13(2):e49-51.  
• Ornoy A, Tenenbaum, A. 2006. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio, and encephalitis viruses. Reprod Toxicol; 21(4):446-457.  
• Panagiotou OA, et al & Costa Rica HPV Vaccine Trial (CVT) Group. 2015. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ 351:h4358457. 
• Selander B, et al. 2009. No evidence of intrauterine transmission of hepatitis A virus from a mother to a premature infant. Acta Paediatr, 98(10):1603-1606 
• Seto MT, et al. 2020. Management of viral hepatitis A, C, D, and E in pregnancy. Best Pract Res Clin Obstet Gynaecol, 68:44-53.  
• Tang J, et al. 2024. Screening for viral hepatitis carriage. Best Pract Res Clin Obstet Gynaecol; 96:102523.  
• Terrault NA, et al. 2021. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol; 18(2):117-130.  
• Van Damme P, et al. 2023. Hepatitis A virus infection; Nat Rev Dis Primers. 9(1):51.  

Selected References:

• Alvarado-Esquivel C, et al. 2015. High seroprevalence of Toxoplasma gondii infection in female sex workers: A case-control study. Eur J Microbiol (Bp); 5(4);285-292. 
• Abdoloe A, et al. 2012. Impaired reproductive function of male rats infected with Toxoplasma gondii. Andrologia; 44 Suppl 1:679-687. 
• Arce-Estrada GE, et al. 2017. Report of an unusual case of anophthalmia and craniofacial cleft in a newborn with Toxoplasma gondii congenital infection. BMC Infect Dis; 17(1):459. 
• Assistant Secretary for Public Affairs (ASPA). 2022. Cook to a safe minimum internal temperature. FoodSafety.gov. https://www.foodsafety.gov/food-safety-charts/safe-minimum-internal-temperatures.  
• Bonetti A, et al. 2025. Risk of Congenital Toxoplasmosis in Newborns from Mothers with Documented Infection: Experience from Two Referral Centres. Pathogens; 14(2):157.   
• Buonsenso D, et al. 2022. Spyramicine and Trimethoprim-Sulfamethoxazole Combination to Prevent Mother-To-Fetus Transmission of Toxoplasma gondii Infection in Pregnant Women: A 28-Years Single-center Experience. Pediatr Infect Dis J; 41(5).  
• Cerisola A, et al. 2025. Congenital toxoplasmosis. Semin Pediatr Neurol; 54:101203.  
• Codaccioni C, et al. 202. Ultrasound features of fetal toxoplasmosis: A contemporary multicenter survey in 88 fetuses. Prenat Diagn; 40(13):1741-1752.  
• Cook AJC, et al. 2000. Sources of toxoplasmosis in pregnant women. BMJ; 321:142-147.  
• Conceição AR, et al. 2021. Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak. Ophthalmology; 128(9):1346-1355. 
• Cortina-Borja M, et al, & European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). 2010. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med; 7(10):e1000351.  
• Couvreur J, et al. 1993. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagn Ther; 8:45-50.  
• Dadoun S, et al. 2024. Congenital toxoplasmosis of the brain caused by infection in late pregnancy. Lancet; 403(10431):1081-1082.  
• Daffos F, et al. 1988. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med; 318(5):271-275.  
• Damar Çakırca T, et al. 2023. Toxoplasmosis: A Timeless Challenge for Pregnancy. Trop Med Infect Dis; 8(1):63. 
• Dard C, et al. 2017. Late diagnosis of congenital toxoplasmosis based on serological follow-up: A case report. Parasitol Int; 66(2):186-189. 
• D’Ercole C, et al. 1995. Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. Prenat Diagn; 15(12):1171-1175. 
• Desmonts G, Couvreur J. 1974. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med; 290(20):1110-6.  
• Dhombres F, et al. 2017. Prognosis of fetal parenchymal cerebral lesions without ventriculomegaly in congenital toxoplasmosis infection. Fetal Diagn Ther; 41(1):8-14.  
• Dubey JP and Jones JL. 2008. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol; 38:1257-1278.  
• Ducrot SB, et al. 2018. Neonatal fever: A puzzling case. Arch Pediatr; 25(7):435-438.  
• Dunn D, et al. 1999. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet; 353:1829-1833.  
• El-Beshbishi SN, et al. 2025. The Impact of Chronic Toxoplasmosis on the Gonadotropic Gonadal Axis in Male Rats. Acta Parasitol; 71(1):3. 
• Elbez-Rubinstein A, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis; 199(2):280-5.  
• Fallahi S, et al. 2018. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. Gynecol Obstet Hum Reprod; 47(3):133-140. 
• Feldman DM, et al. 2016. Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med; 36(2):407-419. 
• Ferreira L, et al. 2024. Congenital toxoplasmosis and auditory disorders: a literature review. Front Psychol; 14:1286211.  
• Flegr J, et al. 2014. Toxoplasmosis can be a sexually transmitted infection with serious clinical consequences. Not all routes of infection are created equal. Med Hypotheses; 83(3):286-289.   
• Foulton W, et al. 1999. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol; 181(4):843-847. 
• Foulton W, et al. 1999. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol; 180(2):410-415. 
• Gilbert RE, Stanford MR. 2000. Is ocular toxoplasmosis caused by prenatal or postnatal infection. Br J Ophthalmol; 84(2):224-226. 
• Giugno S, et al. 2020. Congenital toxoplasmotic chorioretinitis following reinfection. Eur J Obstet Gynecol Reprod Biol; 251:263-265. 
• Groer MW, et al. 2011. Prenatal depression and anxiety in Toxoplasma gondi positive women. Am J Obstet Gynecol; 204(5):433.e1-7.  
• Guerina NG, et al. 1994. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med; 330(26):1858-63.  
• Gundeslioglu OO, et al. 2024. Congenital Toxoplasmosis and Long-term Outcomes. Turkiye Parazitol Derg; 48(1):8-14. 
• Gunturiz ML, et al. 2018. Congenital cerebral toxoplasmosis, Zika, and chikungunya virus infections: a case report. Biomedica; 38(2):144-152.  
• Hampton MM. 2015. Congenital toxoplasmosis: A review. Neonatal Netw; 34(5):274-278.  
• Hide G, et al. 2009. Evidence for high levels of vertical transmission in Toxoplasma gondii. Parasitol; 136:1877-1885.  
• Hlaváčová J, et al. 2021. Male-to-female presumed transmission of toxoplasmosis between sexual partners. Am J Epidemiol; 190(3):386-392. 
• Hlaváčová, Jet al. 2021, Association between latent toxoplasmosis and fertility parameters of men. Andrology; 9: 854-862. 
• Hohlfeld P, et al. 1991. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol; 1(4):241-4.  
• Hohlfeld P, et al. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med; 331(11):695-699.  
• Hosseini SA, et al. 2025. Latent toxoplasmosis and preeclampsia: evidence for the role of chronic infection in pregnancy complications. BMC Pregnancy Childbirth; 25(1):1130. 
• Hunter K, et al. 1983. Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epstein-Barr virus, herpesvirus, rubella, and Toxoplasma gondii. Am J Obstet Gynecol; 145:269-273. 
• Hurt K, et al. 2022. Toxoplasmosis impact on prematurity and low birth weight. PLoS One; 17(1). 
• Jones, CA. 2001. Maternal transmission of infectious pathogens in breast milk. J Paediatr Child Health; 37:576-582.  
• Jones JL et al. 2001. Toxoplasmosis gondii infection in the United States: Seroprevalence and Risk Factors. Am J Epidemiol; 4:357-365.  
• Kahn K, Kahn W. 2018. Congenital toxoplasmosis: An overview of the neurological and ocular manifestations. Parasitol Int; (67(6):715-721.  
• Kalantari N, et al. 2021. Toxoplasma gondii infection and spontaneous abortion: A systematic review and meta-analysis. Microb Pathog; 158:105070.  
• Kaňková Š, et al. 2015. The influence of latent toxoplasmosis on women’s reproductive functions: four cross-sectional studies. Folia Parasitol (Praha); 62:2015.041. 
• Kaňková Š, et al. 2020. Oral sex: A new, and possibly the most dangerous, route of toxoplasmosis transmission. Med Hypotheses; 141:109725.  
• Kazemi F, et al. 2023. Toxoplasma and Risk of Spontaneous Abortion: A Meta-Analysis in A Population of Iranian Women. Int J Fertil Steril; 17(1):7-11. 
• Khamsian EM, et al. 2021. Toxoplasma gondii in milk of human and goat from the desert area in Central Iran. Iran J Parasitol; 16(4): 601-609.  
• Koppe JG, et al. 1986. Results of 20-year follow-up of congenital toxoplasmosis. Lancet; 1:254-255.  
• Li XL, et al. 2014. A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One; 9(5):e97775.  
• Lopez A, et al. 2000. Preventing congenital toxoplasmosis. MMWR Recomm Rep; 49(RR-2):59-68.  
• Lynfield R and Eaton RB. 1995. Teratogen update: Congenital toxoplasmosis. Teratology; 52(3):176-180.  
• Maldonado YA, Read JS; Committee on Infections Diseases. 2017. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics; 139(2):e20163860.  
• Malinger G, et al, 2011. Herrera M. Prenatal brain imaging in congenital toxoplasmosis. Prenat Diagn; 31(9):881-6. 
• Marsolkova K, et al. 2018. Congenital central toxoplasmosis chorioretinitis – case study. Cesk Slov Oftalmol; 74(3):114-118.  
• Martinez VO, et al. 2023. Impact of chronic toxoplasmosis in pregnancy: association between maternal seropositivity for Toxoplasma gondii IgG antibodies and fetal growth restriction. Parasitol Res; 123(1):25.  
• Matini M, et al. 2026. Toxoplasmosis: sperm parameters and testosterone levels in men. J Parasit Dis; 50(1):244-249. 
• Matsui D. 1994. Prevention, diagnosis and treatment of fetal toxoplasmosis. Clin Perinatol; 21(3):675-689.  
• Merz E. 2004. Ultrasound in obstetrics and gynecology. Vol. 1: obstetrics. 2nd ed. New York, NY: Thieme. 
• McLeod R, et al. 2014. Management of congenital toxoplasmosis. Curr Pediatr Rep; 2:166-194. 
• Montoya JG, Liesenfeld O. 2004 Toxoplasmosis. Lancet. 363(9425):1965–1976.  
• Montoya JC & Remington JS. 2008. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis; 47(4):554-566.  
• National Center for Infectious Diseases and the CDC. 2000. Preventing Congenital Toxoplasmosis. MMWR. 49(RR02);57-75.  
• Njoh AA, et al. 2016. Fetal malformation in maternal toxoplasma and rubella co-infection in Cameroon: A case report. J Med Case Rep; 10(1):345. 
• Nourollahpour Shiadeh M, et al. 2020. The prevalence of latent and acute toxoplasmosis in HIV-infected pregnant women: A systematic review and meta-analysis. Microb Pathog; 149:104549.  
• Orevaoghene OE, et al. 2025. Evaluation of Maternal and Neonatal Risk Factors in the Transmission of Toxoplasmosis: A Study on the Detection of Toxoplasma gondii Antibodies in Cord Blood. Ethiop J Health Sci. 2025 Jul;35(4):267-273.  
• Oz HS. 2017. Fetomaternal and pediatric toxoplasmosis. J Pediatr Infect Dis; 12(4): 202-208. 
• Paquet C, Yudin MH; Society of Obstetricians and Gynaecologists of Canada. 2013. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can; 35(1):78-81. 
• Paquet C, Yudin MH. 2018. No. 285-Toxoplasmosis in pregnancy: Prevention, screening, and treatment. J Obstet Gynaecol Can; 40(8):e687-e693. 
• Picone O, et al. 2020. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF. J Gynecol Obstet Hum Reprod; 49(7):101814. 
• Prusa A-R, et al. 2015. The Austrian toxoplasmosis register, 1992-2008. Clin Infect Dis; 60(2): e4-e10. 
• Rajapakse S, et al. 2017. Prophylaxis of human toxoplasmosis: a systematic review. Pathog Glob Health; 111(7):333-342.  
• Red Book: 2024–2027. Report of the Committee on Infectious Diseases (33rd Edition). Toxoplasma gondii Infections (Toxoplasmosis). Red book (Elk Grove Village, Ill.), p.867. 
• Rehman F, et al. 2020. Unpasteurized milk consumption as a potential risk factor for toxoplasmosis in females with recurrent pregnancy loss. J Obstet Gynaecol; 4:1-5. 
• Rico-Torres CP, et al. 2016. Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis; 35(7):1079-1088.  
• Robert-Gangneux F, Darde M-L. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev; 25(2) :264-296.  
• Rojas-Barón L, et al. 2025. Adverse impact of acute Toxoplasma gondii infection on human spermatozoa. FEBS J; 292(17):4720-4736. 
• Sanders AP, et al. 2017. Ocular lesions in congenital toxoplasmosis in Santa Isabel do Ivaí, Paranà, Brazil. Pediatr Infect Dis J; 36(9):817-820.  
• Shojaee S, et al. 2018. The relation of secondary sex ratio and miscarriage history with Toxoplasma gondii infection. BMC Infect Dis; 18(1):307.  
• Simon L, et al. 2020. A case of toxoplasmosis-associated miscarriage with maternal infections four months prior to conception. Parasitol Int; 79:102165.   
• Smit GSA, et al. 2017. Public health impact of congenital toxoplasmosis and cytomegalovirus infection in Belgium, 2013: a systematic review and data synthesis. Clin Infect Dis; 65(4):661-668.  
• Spann MN, et al. 2017. Prenatal toxoplasmosis antibody and childhood autism. Autism Res; 10(5):769-777.  
• Stray-Pedersen B. 1993. Toxoplasmosis in pregnancy. Baillieres Clin Ob Gynecol; 7(1):107-137. 
• Tamma P. 2007. Toxoplasmosis. Pediatr Rev; 28(12):470-1.  
• Torrey EF, et al. 2012. Toxoplasmosis gondii and other risk factors for schizophrenia: an update. Schizophr Bull; 38(3):642-647.  
• The American College of Obstetricians and Gynecologists (ACOG). 2015, reaffirmed 2024. Practice bulletin # 151: Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy. Ob Gyn 125(6): 1510-1525. 
• The Centers for Disease Control and Prevention (CDC):About Toxoplasmosis. 2025. Available at: https://www.cdc.gov/toxoplasmosis/about/index.html. [Accessed 3/31/26]. Clinical Overview of Toxoplasmosis. 2024. Available at: https://www.cdc.gov/toxoplasmosis/hcp/clinical-overview/index.html. [Accessed 3/31/26]. 
• Toxoplasmosis and Breastfeeding. 2025. Available at: https://www.cdc.gov/breastfeeding-special-circumstances/hcp/illnesses-conditions/toxoplasmosis.html. [Accessed 3/31/26]. 
• The Toxoplasmosis Study Group. 1990. Congenital toxoplasmosis. Am J Dis Child; 144:619. 
• Tűzkő N, et al. 2024. Associations between Fetal Symptoms during Pregnancy and Neonatal Clinical Complications with Toxoplasmosis. Children (Basel); 11(9):1111.  
• Villena I, et al. 1998. Prenatal diagnosis of congenital toxoplasmosis transmitted by an immunocompetent woman infected before conception. Reims Toxoplasmosis Group. Prenat Diagn; 18(10):1079-81. 
• Walana W, et al. 2026. Prevalence, risk factors, diagnosis and outcomes of Toxoplasma gondii infection in pregnancy: A review. Parasitol Int; 110:103143.  
• Wallon M, et al. 2014. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Pediatrics; 133(3):e601-8.  
• Wallon M, Peyron F. 2018. Congenital toxoplasmosis: A plea for a neglected disease. Pathogens; 7(1):25.  
• Werner H, et al. 2017. Neuroimaging findings of congenital toxoplasmosis, cytomegalovirus, and Zika virus infections: A comparison of three cases. J Obstet Gynaecol Can; 39(12):1150-1155.  
• Wilson CB. 1980. Development of adverse sequelae in children born with subclinical toxoplasmosis infection. Pediatrics; 66(5):767-774.  
• Zhang F, et al. 2024. Toxoplasma gondii Causes Adverse Pregnancy Outcomes by Damaging Uterine Tissue-Resident NK Cells That Secrete Growth-Promoting Factors. J Infect Dis; 229(2):547-557.  
• Zhao F, et al. 2026. Clinical characteristics and associated risk factors for diminished ovarian reserve among Chinese women: a matched case-control study. Front Endocrinol (Lausanne); 17:1767835. 

Selected References:

• Bang Madsen K, et al. 2023. In utero exposure to ADHD medication and long-term offspring outcomes. Molecular psychiatry; 28(4)1739–1746.  
• Boutroy MJ, et al. 1988. Clonidine: Placental transfer and neonatal adaption. Early Hum Dev; 17:275-286. 
• Bunjes R, Schaefer C. 1993. Clonidine and breast-feeding. Clinical Pharm 12:178-9. 
• Frazier, LM, et al. 2020. Emerging therapies for the treatment of neonatal abstinence syndrome. The Journal of Maternal-Fetal & Neonatal Medicine; 6:1-9. 
• Horvath JS, et al. 1985. Clonidine hydrochloride a safe and effective antihypertensive agent in pregnancy. Obstet Gyneco;l 66:634-8. 
• Huisjes, et al. 1986. Is clonidine a behavioural teratogen in the human? Early Hum Dev; 14:43-8. 
• Khan A, et al. 1970. Clonidine (Catapres): a new anti-hypertensive agent. Cur Ther Res; 12:10. 
• Liu X, et al. 2026. Clonidine compromises human sperm functions. Reproductive Toxicology; 140, 109164.  
• Maina A, et al. 2014. Transdermal clonidine in the treatment of severe hyperemesis: A pilot randomized controlled trial (CLONEMESI). BJOG: An International Journal of Obstetrics & Gynaecology; 121,1556–1562. 
• Mirmiran M. 1986. The importance of fetal/neonatal REM sleep. Eur J Obstet Gynecol Reprod Biol; 21:283-91. 
• Rothberger S, et al. 2010. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens; 23(11):1234-40. 
• Sevrez C, et al. 2014. [Transplacental or breast milk intoxication to clonidine: a case of neonatal hypotonia and drowsiness]. Arch Pediatr; 21(2):198-200.  
• Stoll C, et al. 1979. Robert’s syndrome and clonidine. J Med Genet; 16:486-8. 
• Terada H, et al. 2005. Oral clonidine advances spermatogenesis in oligozoospermic patients with spermatogenetic maturation arrest. International journal of urology: official journal of the Japanese Urological Association; 12(9),815–820.  
• Tuimala R, et al. 1985. Clonidine in the treatment of hypertension during pregnancy. Annales Chirurgiae et Gynaecologiae Supplementum; 197,47–50. 
• Tsai TH, et al. 1982. Teratologic and reproductive studies of lofexidine. Arzneimittelforsh; 32:962-6. 
• Zangeneh F, et al. 2022. The first report of clonidine in vivo/in vitro effects on infertile women with polycystic ovary syndrome (in vivo/in vitro study). Journal of the Institute of Obstetrics and Gynaecology; 42(5),1331–1339.  

Selected References:

• Allocca M, et al. 2018. Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men. Eur J Gastroenterol Hepatol. 30(3):316-322. 
• Asthana R, et al. 2025. Meta-analysis and systematic review on sulfasalazine/5-ASA use during pregnancy: Impact on neonatal and pregnancy outcomes. Reprod Toxicol135:108939. 
• Ban L et al. 2014. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology. 146 (1):76-84. Banerjee, A et al. 2019. Inflammatory
• Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis. Endocrine, metabolic & immune disorders drug targets, 19(7), 959–974.  
• Chermesh I & Eliakim R. 2004. Mesalazine-induced reversible infertility in a young male. Dig Liver Dis 36:551-2. 
• Diav-Citrin O, et al. 1998. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology; 114:23-28.  
• Gaidos J. & Kane SV. 2020. Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications. Digestive diseases and sciences, 10.1007/s10620-020-06271-w. Advance online publication. 
• Hosseini-Carroll P, et al. 2015. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World J Gastrointest Pharmacol Ther. 6(4):156-171. 
• Ito S, et al. 1993. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 168:1393-9. 
• Källén B. 2014. Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring. Scand J Gastroenterol; 49(4):442-8.  
• Mahadevan U, Matro R. Care of the pregnant patient with inflammatory bowel disease. Obstet Gynecol. 2015;126:401-12.  
• Maliszewska, AM, et al. 2017. Inflammatory bowel disease and pregnancy. Ginekologia Polska, 88(7), 398-403. 
• Marteau P & Devaux CB. 1994. Mesalazine during pregnancy. Lancet 344(8938):1708-1709. 
• Moskovitz DN, et al. 2004. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99(4):656-661. 
• Moretti ME. 1998. Prospective follow-up of infants exposed to 5-aminosalicylic acid containing drugs through maternal milk. Theses Canada. Moretti ME, et al. 1998. Prospective follow-up of infants exposed to 5-aminosalicylic
• acid containing drugs through maternal milk. J Clin Pharmacol. 38:867. 
• Nelis GF. 1989. Diarrhoea due to 5-aminosalicylic acid in breastmilk. Lancet 1:383. 
• Nielsen OH, et al. 2014. IBD medications during pregnancy and lactation. Nat Rev Gastroenterol Hepatol. 11(2):116-127.  
• Norgård, B et al. 2003. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut, 52(2), 243–247.  
• Pervez, H, et al. 2019. The Impact of Inflammatory Bowel Disease on Pregnancy and the Fetus: A Literature Review. Cureus, 11(9), e5648.  
• Shin T, et al. 2014. Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility. Syst Biol Reprod Med. 60(6); 373-376. 
• Silverman DA, et al. 2005. Is mesalazine really safe for use in breastfeeding mothers? Gut 54: 170-1. 
• Watanabe, C. et al. 2020. Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes. Digestive diseases and sciences, 10.1007/s10620-020-06221-6. Advance online publication.  
• Wiersma TK, et al. 2022. The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review. Pharmaceutics. 14(6):1241. 
• Xu YL, et al. 2017. Inflammatory bowel disease in pregnancy: A report of 7 cases and review of the literature. Int J Clin Exp Med; 10:5525-32.